We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.82B
AUM Growth
+$380M
Cap. Flow
+$289M
Cap. Flow %
10.23%
Top 10 Hldgs %
47.61%
Holding
326
New
24
Increased
122
Reduced
122
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Healthcare 6.65%
3 Financials 4.76%
4 Industrials 4.1%
5 Consumer Discretionary 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWS icon
276
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$215K 0.01%
1,953
-257
-12% -$27.1K
DGRW icon
277
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
$214K 0.01%
+3,207
New +$204K
DD icon
278
DuPont de Nemours
DD
$18.5B
$212K 0.01%
2,360
-48
-2% -$4.13K
VB icon
279
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$211K 0.01%
+1,062
New +$201K
JCI icon
280
Johnson Controls International
JCI
$88.8B
$208K 0.01%
+3,053
New +$188K
PPG icon
281
PPG Industries
PPG
$24.6B
$206K 0.01%
+1,392
New +$194K
DAL icon
282
Delta Air Lines
DAL
$57.5B
$206K 0.01%
+4,334
New +$160K
SCHD icon
283
Schwab US Dividend Equity ETF
SCHD
$103B
$203K 0.01%
+8,376
New +$200K
VOX icon
284
Vanguard Communication Services ETF
VOX
$5.59B
$203K 0.01%
1,906
-3,096
-62% -$311K
WBA
285
DELISTED
Walgreens Boots Alliance
WBA
$202K 0.01%
7,073
-1,302
-16% -$42.4K
CLM icon
286
Cornerstone Strategic Value Fund
CLM
$2.22B
$189K 0.01%
22,860
-1,665
-7% -$13K
CGBD icon
287
Carlyle Secured Lending
CGBD
$694M
$169K 0.01%
11,623
+589
+5% +$8.19K
ADMA icon
288
ADMA Biologics
ADMA
$1.96B
$167K 0.01%
45,267
CRF
289
Cornerstone Total Return Fund
CRF
$1.16B
$157K 0.01%
20,024
+1,043
+5% +$7.72K
TCPC icon
290
BlackRock TCP Capital
TCPC
$273M
$156K 0.01%
14,276
+1,545
+12% +$16.2K
INVA icon
291
Innoviva
INVA
$1.55B
$155K 0.01%
12,212
GLAD icon
292
Gladstone Capital
GLAD
$422M
$153K 0.01%
7,832
+918
+13% +$17.4K
GBDC icon
293
Golub Capital BDC
GBDC
$3.34B
$150K 0.01%
+11,096
New +$147K
HBAN icon
294
Huntington Bancshares
HBAN
$34.4B
$143K 0.01%
13,305
TPVG icon
295
TriplePoint Venture Growth BDC
TPVG
$184M
$137K ﹤0.01%
+11,633
New +$131K
VLY icon
296
Valley National Bancorp
VLY
$7.9B
$112K ﹤0.01%
14,500
IOVA icon
297
Iovance Biotherapeutics
IOVA
$1.82B
$107K ﹤0.01%
+15,233
New +$109K
ISPC icon
298
iSpecimen
ISPC
$2.72M
$93.8K ﹤0.01%
82
NAK
299
Northern Dynasty Minerals
NAK
$784M
$76.5K ﹤0.01%
318,950
HRTX icon
300
Heron Therapeutics
HRTX
$93.9M
$55.5K ﹤0.01%
47,804
+10,106
+27% +$18K

Similar funds

Grimes & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Grimes & Company held 326 positions worth $2.82B, up 16% from $2.44B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Grimes & Company deployed $289M of net new capital in Q2 2023, opening 24 new positions and adding to 122 existing holdings. Its largest new stake was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Grimes & Company's largest Q2 2023 buy was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.
  • Grimes & Company added most to iShares Russell 2000 ETF in Q2 2023, an estimated $160M increase.
  • Grimes & Company's biggest Q2 2023 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q2 2023, selling an estimated $17M.
  • Grimes & Company's ten largest holdings make up 48% of its $2.82B portfolio in Q2 2023.
  • Grimes & Company opened 24 new positions and closed 11 in Q2 2023.
  • Grimes & Company's portfolio value rose 16% quarter-over-quarter to $2.82B.

Based on Grimes & Company's 13F filing for Q2 2023, filed 19 Jul 2023.